Overview

A Human Factors Study to Evaluate a Novel Intracanalicular Insertion Device in Healthy Subjects

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label, multi-center, bilateral, human factors study designed to evaluate the utilization and safety of a novel intracanalicular insertion device in healthy subjects and to evaluate the concentration of DEXTENZA in tears. Each subject's participation is expected to last for approximately 1 month from the DEXTENZA insertion.
Phase:
Early Phase 1
Details
Lead Sponsor:
Ocular Therapeutix, Inc.
Treatments:
Dexamethasone